Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, ...

Pfizer’s oral antiviral Paxlovid (nirmatrelvir/ritonavir) does not appear to significantly ease symptoms in patients with ...

A study by Stanford University researchers found that a 15-day course of Pfizer's Paxlovid did not relieve symptoms of long ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Pfizer Inc. (NYSE:PFE) ...

Pfizer has been working on a vaccine for the H5N1 influenza virus since 2023 as part of the company’s “broader pandemic preparedness efforts.” The company said May 28 that a vaccine candidate has ...

The domestic Marlboro parent has struggled in the past decade, but it remains an appealing dividend stock with an 8.4% yield.

Intel’s new Xeon server processors, the Xeon 6 family, will counter AMD (AMD) and Nvidia. Drug giant Pfizer (PFE) failed twice to break out above $29.99, a bearish signal. Although the FDA selected ...

COVID-19 treatment Paxlovid was found to be ineffective in lessening the symptoms of long COVID, according to a new study by ...

Stocks Analysis by Investing.com (Francesco Casarella) covering: Pfizer Inc. Read Investing.com (Francesco Casarella)'s ...

An ongoing study showed that 60% of lung cancer patients who took a drug called Lorbrena remained alive and disease-free ...

Initial triplet combination of RLY-2608 + atirmociclib + fulvestrant to be evaluated in patients with PI3Kα-mutated HR+/HER2- ...

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Pfizer Inc. ...